Assessing Free Immunoglobulin Light Chains in Patients With Myeloma - Related Studies

Assessing Free Immunoglobulin Light Chains in Patients With Myeloma

This study has been completed.

Study NCT00301275. Last updated on March 9, 2006. Information provided by Royal Marsden NHS Foundation Trust

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Multiple Myeloma

2	Additional conditions recognized in this trial
		Neoplasms, Plasma Cell

3	More general conditions related to this trial
		Blood Protein Disorders
		Cardiovascular Diseases
		Hematologic Diseases
		Hemorrhagic Disorders
		Hemostatic Disorders
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type
		Paraproteinemias
		Vascular Diseases

4	Additional drug interventions recognized in this trial
		Immunoglobulin Light Chains

5	More general drug interventions related to this trial
		Immunologic Factors
		Pharmacologic Actions
		Physiological Effects of Drugs

6	Sponsors listed in this trial
		Royal Marsden NHS Foundation Trust